Our Partners

Thank you to our partners

To discuss Corporate Partnerships, Additional Sponsorship Opportunities, unique fundraising ideas or more about the Walk, and other ways you can be involved please email our Event Director or call 866-PUW-WALK (789-9255).


Sponsors for the 2018 Walk:


    Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Our spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. Read more.



AbbVie, a global, researched-based biopharmaceutical company, is committed to educating patients and caregivers about Parkinson’s disease to raise awareness about the condition, and further research to improve the lives of those living with and impacted by this disease. AbbVie is a proud sponsor of the Parkinson’s Unity Walk.  Read more.     At US WorldMeds, we hold a fundamental belief that our science has the potential to improve the lives of Parkinson’s patients. US WorldMeds’ commitment to Parkinson’s patients is reflected in all that we do. Our pipeline of development projects, along with our two currently available PD treatments, reflects our resolve to bring innovative solutions to Parkinson’s patients.  Read more.



At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world — in nutrition, diagnostics, medical devices and branded generic pharmaceuticals — that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve. Read more.             Adamas uses its deep understanding of time-dependent biology to redefine the treatment experience for patients suffering from chronic neurological diseases. Building upon the commercial launch of GOCOVRI™ (amantadine) extended release capsules (previously ADS-5102), the first and only FDA-approved medicine for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, the company’s goal is to create and commercialize a new generation of medicines intended to lessen the burden of disease on patients, caregivers and society. Read more.
 Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, strives for global leadership in psychiatry and neurology by improving the lives of patients.  One of the world’s leading companies specializing in brain disorders, Lundbeck is focused on innovating treatments for depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease. Read more.              UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7,500 people in approximately 40 countries, the company generated revenue of €4.2 billion in 2016. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news.  Read more.



Acorda is proud to support the Parkinson’s Unity Walk, and we are excited to join people with Parkinson’s, and their family and friends in April to raise awareness of Parkinson’s. As an emerging leader in Parkinson’s disease therapeutic development, our goal is to support the Parkinson’s community through medical research, educational initiatives and programs like the Unity Walk that help people with Parkinson’s live well.   Read more.   Boston Scientific is a proud sponsor of the 2018 Parkinson’s Unity Walk. Our FDA-approved therapy for patients with Parkinson’s disease is backed by rigorous clinical data and the experiences of our patients around the world. To learn more about DBS from Boston Scientific, and to hear from our patients in their own words, visit DBSandMe.com.  Read more.

Impax is an integrated specialty pharmaceutical company focused on developing, manufacturing, and marketing generic and specialty pharmaceutical products. We apply our formulation and drug delivery expertise to the development of solid oral dose and specialty generics in addition to the development of central nervous system disorder branded products. Impax is proud to support the Parkinson’s Unity Walk as part of our commitment to enhancing patient lives through advancing knowledge of neurological disorder treatments. Please come visit our tent to learn more about a potential treatment for Parkinson’s disease and our Patient Support Program.  Read more.   LSVT Global has researched and developed highly effective speech, physical and occupational therapy programs (LSVT LOUD and LSVT BIG) for people with Parkinson's disease.  Visit our website to find LSVT Certified Clinicians near you, exercise videos for improving voice and movements, free online and live educational events, and a speech exercise software program.  Read more.
Deep brain stimulation (DBS) development started in 1987 and Medtronic has been the leader in the field ever since, with over 150,000 implanted with Medtronic DBS Therapy. The Medtronic DBS Therapy system has been rigorously tested with clinical evidence and is FDA approved for people with Parkinson’s who had recent onset of movement symptoms as well as those with longer-standing movement symptoms. To learn more about Medtronic DBS Therapy, please visit MedtronicDBS.com.    Read more.    



Charles and Vivian Sukenik Philanthropic Fund





The Kenneth Aidekman Family Foundation


Neurocrine Biosciences







Carol and Bob Perlman










We also thank:

City of New York Parks & Recreation and The New York City Police Department